Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Masahiko Shimura
Real-World Management of Treatment-Naïve Diabetic Macular Oedema: 2-Year Visual Outcome Focusing on the Starting Year of Intervention From STREAT-DMO Study
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Correction To: Current Practice in the Management of Branch Retinal Vein Occlusion in Japan: Survey Results of Retina Specialists in Japan
Japanese Journal of Ophthalmology
Medicine
Ophthalmology
Related publications
One-Year Treatment Outcomes of Ziv-Aflibercept for Treatment-Naïve Macular Oedema in Branch Retinal Vein Occlusion
Acta Ophthalmologica
Medicine
Ophthalmology
Real-World Experience of Fluocinolone Acetonide (0.2 Μg/Day) Intravitreal Implant in the Treatment of Diabetic Macular Oedema
European Ophthalmic Review
Factors Predicting Outcome of Vitrectomy for Diabetic Macular Oedema: Results of a Prospective Study
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Three Year Real‐life Outcomes From the Use of the Fluocinolone Acetonide Implant (Iluvien) in the Treatment of Refractory DMO
Acta Ophthalmologica
Medicine
Ophthalmology
Costs Associated With the Management and Morbidity of Diabetic Macular Oedema and Macular Oedema Secondary to Retinal Vein Occlusion
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Three-Year Results From the Retro-Ideal Study: Real-World Data From Diabetic Macular Edema (DME) Patients Treated With ILUVIEN® (0.19 Mg Fluocinolone Acetonide Implant)
European Journal of Ophthalmology
Medicine
Ophthalmology
Diabetic Foot Management; A 10-Year Study.
Basrah Journal of Surgery
Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data From a Prospective Study and Predictive Factors for Visual Outcome
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Aflibercept – Setting Its Sights on Diabetic Macular Oedema
European Ophthalmic Review
